Hrt Financial »

Intra Cellular Therapies shares owned by Hrt Financial

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Hrt Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.2M 26k 83.52
2024-09-30 $12M 167k 73.17
2024-06-30 $17M 240k 68.49
2023-12-31 $985k 14k 71.55
2022-09-30 $478k 10k 46.50
2021-09-30 $1.5M 39k 37.27
2020-12-31 $335k 11k 31.77

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Apple Put
Ishares Tr Russell 2000 Etf (IWM)
Nvidia Corporation Put
Microsoft Corporation (MSFT)
Microsoft Corp Put
Johnson & Johnson (JNJ)
Amphenol Corp Cl A (APH)
Applovin Corp Call
Grab Holdings Class A Ord (GRAB)
Apple Call
Tesla Motors (TSLA)

View all positions for Hrt Financial

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies